- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07542431
Effekten av hundeadopsjon og trening hos veteraner med posttraumatiske stressymptomer og/eller andre psykiske helsetilstander (VCRM)
Vurdering av biopsykososiale indikatorer knyttet til respons på hundebasert intervensjonsbehandling hos veteraner med posttraumatiske stressymptomer og/eller andre psykiske helseproblemer
The goal of this single-arm study is to learn if a dog adoption and training program can treat, prevent in [describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers]. The main questions it aims to answer are:
- Does the dog adoption and training program decrease posttraumatic stress symptoms in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease stress and improve psychosocial health in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease inflammation, increase oxytocin, and change the structure and resting-state function of specific brain regions in veterans with self-reported posttraumatic stress symptoms?
Participants will:
- Attend eight one-hour professional dog training sessions within a 10-week period.
- Visit the clinical research unit four times during the study for data collection.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Beth A Pratt, PhD
- Telefonnummer: 561-297-4227
- E-post: bpratt4@health.fau.edu
Studiesteder
-
-
Florida
-
Boca Raton, Florida, Forente stater, 33431
- Rekruttering
- Florida Atlantic University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Military veteran with self-reported posttraumatic stress symptoms and/or other mental health conditions
- Over 18 years of age
- Applied and approved to adopt a shelter dog for training through the Humane Society of Broward County in Fort Lauderdale, Florida
- English speaker (written and spoken)
- Home internet access via tablet, computer or smartphone.
Exclusion Criteria:
- Fear of dogs
- Allergies to pet dander
- Uncorrected hearing or visual impairment.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Study Intervention
Within-subjects design |
Eight, one-hour professional dog training sessions over 8-10 weeks |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in self-reported posttraumatic stress disorder (PTSD) symptoms from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) is a 20-item self-report measure of PTSD symptoms with scores ranging from 0 to 80. |
From enrollment to 4 weeks post-intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in depression symptom severity from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptoms with scores ranging from 0 to 27. |
From enrollment to 4 weeks post-intervention
|
|
Change in anxiety symptom severity from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Generalized Anxiety Disorder-7 (GAD-7) is a is a 7-item self-report measure of anxiety symptoms with scores ranging from 0 to 21. |
From enrollment to 4 weeks post-intervention
|
|
Change in perceived stress severity from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure of perceived stress symptoms with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in sleep disturbance from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Patient-Reported Outcomes Measurement Information System Sleep 8b (PROMIS Sleep 8b) is an 8-item self-report measure of sleep quality over the past 7 days with raw scores ranging from 8 to 40 and standardized T scores ranging from 28.9 to 76.5. |
From enrollment to 4 weeks post-intervention
|
|
Change in loneliness from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Revised UCLA Loneliness Scale is a 20-item self-report measure of loneliness with scores ranging from 20 to 80. |
From enrollment to 4 weeks post-intervention
|
|
Change in alcohol use from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Alcohol Use Disorder Identification Test (AUDIT) is a 10-item self-report measure of alcohol use with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis use from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Cannabis Use Disorder Identification Test (CUDIT) is an 8-item self-report measure of cannabis use with scores ranging from 0 to 32. |
From enrollment to 4 weeks post-intervention
|
|
Change in salivary oxytocin levels from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Oxytocin is a neurotransmitter that plays a role in determining social behavior. Salivary oxytocin levels range from 6.4-1000 pg/mL. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-1 beta (IL-1β) from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
IL-1β is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-1β is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-6 (IL-6) from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
IL-6 is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-6 is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in tumor necrosis factor-alpha (TNF-alpha) from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
TNF-alpha is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. TNF-alpha is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in alcohol demand for participants who answer "yes" to alcohol consumption in the AUDIT measure from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Alcohol Purchase Task is a tool to measure alcohol demand by asking individuals how many drinks they would consume at prices ranging from free to high, using behavioral economic indices for scoring. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis demand for participants who answer "yes" to cannabis use from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention
|
Cannabis Purchase Task is a tool to measure cannabis demand by assessing how much an individual purchases at increasing prices. |
From enrollment to 4 weeks post-intervention
|
|
Change in Magnetic Resonance Imaging (MRI) biomarkers from baseline to 4 weeks post-intervention
Tidsramme: Pre-intervention and 4 weeks post-intervention
|
Optional participation in an MRI to detect changes in the structure and resting-state function of specific brain regions (anterior cingulate, amygdala, hippocampus, and insula) |
Pre-intervention and 4 weeks post-intervention
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Beth A Pratt, PhD, Florida Atlantic University
- Hovedetterforsker: Cheryl A Krause-Parello, PhD, Florida Atlantic University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- IRB2310227
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .